More News

05 May 2017 Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value
05 May 2017 Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases
04 May 2017 Novartis exercises exclusive option agreement with Conatus for the treatment of NASH
03 May 2017 Servier and miRagen extend collaboration for the research, development and commercialization of microRNA-targeting therapeutics
03 May 2017 Selecta Biosciences Obtains License for Recombinant Immunotoxin LMB-100 from National Cancer Institute (NCI) for Pancreatic Cancer, Mesothelioma and Other Cancers
03 May 2017 bluebird bio Enters Lentiviral Vector Patent License Agreement with GlaxoSmithKline for Commercialization of Gene Therapies
03 May 2017 Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics
03 May 2017 TxCell and Inserm collaborate to develop new CAR-Tregs in transplantation and multiple sclerosis
03 May 2017 Magenta Therapeutics Advances Stem Cell Transplantation Strategy with $50 Million Series B Financing, Licensing of Clinical-Stage Stem Cell Expansion Program and Strategic Partnership with Be The Match BioTherapies
03 May 2017 bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies
03 May 2017 Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
02 May 2017 Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents
02 May 2017 NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm
02 May 2017 Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
28 Apr 2017 Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease Therapeutics
26 Apr 2017 Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration
26 Apr 2017 Xenon Expands Ion Channel Neurology Pipeline with Acquisition of New Potassium Channel Modulator for the Treatment of Epilepsy
26 Apr 2017 Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialise Vadadustat in Europe, China and Other Territories
26 Apr 2017 Sienna Biopharmaceuticals Announces $40 Million Series B Financing
25 Apr 2017 Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™
25 Apr 2017 Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the US and Canada
25 Apr 2017 Merck Divests Biosimilars Business to Fresenius
20 Apr 2017 Lion Biotechnologies Announces Strategic Alliance with MD Anderson Cancer Center to Conduct Clinical Trials of TILs in Multiple Solid Tumors
19 Apr 2017 Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes
18 Apr 2017 Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing